Knopp Biosciences
PrivateLast Round
Series C
Nov 11, 2020
Total Funding Raised
$124.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Knopp Biosciences operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Series C round in November 2020.
Knopp Biosciences is a biopharmaceutical company that manages a portfolio of equity securities and future product royalties following the divestiture of its drug development programs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Knopp Biosciences Comparables
Compare Knopp Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Areteia Therapeutics | 91% | |
| Kinaset Therapeutics | 77% | |
| Sitryx | 76% |
For institutional investors. Book with your work email.
Knopp Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 11, 2020 | ||||
| Grant | Sep 26, 2019 | ||||
| VC Round | Jul 9, 2019 | ||||
| Grant | Sep 5, 2018 | ||||
| Grant | Oct 23, 2017 | ||||
VC Round | Sep 30, 2015 |
For institutional investors. Book with your work email.
Knopp Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Innovation Works | Series A |
| Kramer Capital Partners | Series C, Series B, Series A |
| LaunchCyte LLC | Series B, Series A |
| National Institutes of Health (NIH) | Grant |
| Saturn Partners | Series C, Series B, Series A |
| Chuangxin Innovation Works | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 91% MoM.
- Nov 11, 2020
$14M round led by Solas BioVentures
For institutional investors. Book with your work email.
Knopp Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Knopp Biosciences's valuation, stock price, and market status.
Is Knopp Biosciences a public or private company?
Knopp Biosciences is a private company.
What is the current stock price of Knopp Biosciences?
Knopp Biosciences is a private company, so its shares have no public market price. Caplight tracks Knopp Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Knopp Biosciences worth (valuation)?
Valuation information for Knopp Biosciences is not publicly available.
Can I buy Knopp Biosciences stock?
Knopp Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Knopp Biosciences's last funding round?
Knopp Biosciences's most recent funding round was Series C on November 11, 2020.
Who are the main investors in Knopp Biosciences?
Key investors in Knopp Biosciences include National Institutes of Health (NIH), Saturn Partners, Solas BioVentures.
Will Knopp Biosciences IPO soon?
No public IPO plans have been announced for Knopp Biosciences.
How can I track Knopp Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Knopp Biosciences's shares on secondary markets.